WALTHAM, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, announced its financial and operating results for the quarter ended June 30, 2018. “Our focus in the second quarter of 2018 was on
BALTIMORE (PRWEB) AUGUST 08, 2018 Orthopedics & Joint Replacement at Mercy Medical Center now offers a new advanced minimally invasive surgical option for patients needing total knee replacement: MAKOplasty Total Knee Replacement Surgery using robotic technology. According to Dr. Marc Hungerford, Chief of the Division of Orthopedics at Mercy, this knee replacement treatment option is designed to relieve the pain
SAN DIEGO and ERLANGEN, Germany, Aug. 9, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) and Siemens Healthineers today announced a strategic partnership focused on technology development, marketing and commercial activities to advance clinical outcomes in minimally invasive spine surgery. NuVasive is an innovation leader in spine health technology, focused on transforming spine surgery with minimally disruptive, predictable and clinically reproducible procedurally-integrated solutions,
MARIETTA, Ga., Aug. 9, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received regulatory approval from the Therapeutics Goods Administration (TGA) in Australia to market and sell a broad array of the Company's dehydrated Human Amnion/Chorion Membrane (dHACM) products. This includes EpiFix®, AmnioFix®, EpiBurn®, AmnioFix Injectable, and
August 08, 2018 YOKNEAM, Israel--(BUSINESS WIRE)--Augmedics has begun a first-in-human clinical trial of its xvision-spine (XVS) augmented-reality surgical navigation system at Sheba Tel Hashomer Medical Center and Asaf Harofeh Medical Center, in Israel. Led by Co-Principal Investigators Dr. Ran Harel and Prof. Yigal Mirovsky, the open label, prospective, single arm, multi-center study will evaluate the safety,
WARSAW, Ind., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the second quarter ended June 30, 2018. Second Quarter & Recent Highlights Increased total revenue to $15.1 million for second quarter 2018, up 27.7% from $11.8 million in second
RAYNHAM, Mass., Aug. 8, 2018 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI"), a privately-held, established medical technology company targeting the $15 billion global hip and knee replacement device market, announced today that Brigham Redd, M.D., of Liljenquist & Redd Orthopedic Surgery, is the first surgeon in Idaho to offer OMNIBotics, an advanced robotic-assisted treatment option for total knee replacement. This innovative total knee replacement
By Neel Anand, M.D., Contributor - Aug. 6, 2018 AS THE AMERICAN legislature and medical community continue efforts to stem the tide of the growing opioid crisis in our country, researchers are working diligently to highlight what a dangerous path doctors may be putting patients on when writing prescriptions for opioid medications to address chronic back pain as
BELGRADE, MT, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the second quarter ended June 30, 2018. Summary of Second Quarter 2018 Financial Highlights and Recent Announcements: Revenue for the second quarter of
August 07, 2018 CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today provided a business update and reported financial results for the quarter ended June 30, 2018. Richard Toselli, M.D., President and Chief Executive Officer of InVivo, commented, “We continued to make progress in the second quarter of 2018, as the net proceeds of $13.5 million from
